Patent Ductus Arteriosus Clinical Trial
Official title:
Effect of Patent Ductus Arteriosus on Splanchnic Oxygenation at Enteral Feeding Introduction in Preterm Infants
Patent ductus arteriosus (PDA) is common in preterm infants. In the presence of a large PDA,
significant systemic to pulmonary shunting occurs, which may results in pulmonary
hyperperfusion and systemic hypoperfusion. As consequence of splanchnic hypoperfusion ensuing
from left-to-right PDA shunting, a possible association between hemodynamically significant
PDA and adverse gastrointestinal outcomes has been reported.
An impaired blood flow velocity in superior mesenteric artery, evaluated by Doppler
ultrasound, has been previously reported before and after feeds in infants with large PDA,
whereas evidence on PDA effect on splanchnic tissue oxygenation, measured by Near Infrared
Spectroscopy, is scarce and controversial.
This study aims to evaluate whether splanchnic oxygenation patterns in response to enteral
feeding introduction in preterm infants may be affected by PDA status.
Patent ductus arteriosus (PDA) is a common condition among preterm infants. In the presence
of a large PDA, significant systemic to pulmonary shunting occurs, possibly resulting in
pulmonary blood flow overload and systemic hypoperfusion. A possible association with
hemodynamically significant PDA and the occurrence of adverse gastrointestinal outcomes has
been reported as a possible consequence of mesenteric hypoperfusion ensuing from
left-to-right shunt through the PDA.
Previous attempts to assess by Doppler ultrasound the effect of PDA on blood flow velocity in
superior mesenteric artery (SMA BFV) showed a decreased SMA BFV before and after feedings and
attenuated postprandial increases in infants with large PDA. Near-infrared spectroscopy
(NIRS) provides a non-invasive measurement of regional tissue oxygen saturation and has been
previously applied in neonatal settings for the monitoring of cerebral (CrSO2) or splanchnic
(SrSO2) oxygen saturation. Current evidence on the effect of PDA on SrSO2 is scarce and
controversial; moreover, a possible effect of PDA on SrSO2 patterns in response to enteral
feeding introduction has not been evaluated yet.
This study aims to evaluate whether SrSO2 patterns in response to enteral feeding
introduction in preterm infants may be affected by the ductal status. The development of
intestinal complications in relation to PDA are also evaluated.
Preterm infants <32 weeks admitted to the Neonatal Intensive Care Unit (NICU) are
consecutively enrolled in the study if younger than 3 days and if no enteral feeding has been
administered prior to the enrollment.
Written, informed consent to participate in the study is obtained from the parents/legal
guardians of each infant before introducing enteral feeding.
At the time of enteral feeding introduction, the enrolled infants undergo a continuous
monitoring of CrSO2 and SrSO2 by means of INVOS 5100 oximeter. NIRS recording is performed
from 30 minutes before to 3 hours after feeding administration. CrSO2 and SrSO2 are recorded
every 5 seconds. Values recorded before, during and after feeding administration are
clustered into 5-minute intervals and considered for statistical analysis.
Splanchnic-cerebral oxygen ratio (SCOR), which derives by the ratio between SrSO2 and CrSO2
and has been previously proposed as a valid marker for gut hypoxia-ischemia, is also
calculated.
As per normal routine, an echocardiographic evaluation is performed before enteral feeding
introduction, in order to evaluate hemodynamics and PDA status of the infant. In relation to
the PDA status, enrolled infants are divided into the following groups: PDA
(echocardiographic evidence of patent ductus arteriosus at the time of first feed) and noPDA
(echocardiographic evidence of closed ductus arterious at the time of first feed).
Neonatal characteristics, including gestational age, birth weight, antenatal Doppler status,
and echocardiographic PDA characteristics at the introduction of enteral feeding and the
occurrence of intestinal complications during hospital stay, defined as the development of
feeding intolerance (enteral feeding withholding for at least 24 hours because of
gastrointestinal symptoms), necrotizing enterocolitis and spontaneous intestinal perforation,
are recorded in a specific case report form.
SrSO2, CrSO2 and SCOR patterns in response to first feed are evaluated and compared between
PDA and noPDA infants and adjusted for possible influencing clinical variables using a
multivariate model. Moreover, the rate of intestinal complications is compared between the
two study groups by chi-square test. Data are analyzed using IBM SPSS Statistic version 25
(IBM Corporation, IBM Corporation Armonk, New York, United States).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04986839 -
PAIR (Paracetamol and Ibuprofen Research) Pilot Trial
|
Phase 2/Phase 3 | |
Recruiting |
NCT03648437 -
Paracetamol And Ibuprofen/Indomethacin in Closing Patent Ductus Arteriosus
|
Phase 1 | |
Completed |
NCT04126512 -
Timing of Surgical PDA Ligation and Neonatal Outcomes
|
||
Not yet recruiting |
NCT06045130 -
PUFAs in Preterm Infants
|
||
Completed |
NCT00217191 -
Ibuprofen and Renal Function in Premature Infants
|
Phase 4 | |
Not yet recruiting |
NCT02894970 -
A New Device for Measuring of Lung Photoplethysmography and Pulmonic Arterial Saturation
|
N/A | |
Completed |
NCT02621528 -
Lifetech CeraFlex™ Post-Market Surveillance Study
|
N/A | |
Completed |
NCT03551600 -
Splanchnic and Renal Tissue Oxygenation During Enteral Feedings in Neonates With Patent Ductus Arteriosus
|
||
Terminated |
NCT03982342 -
Preliminary Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low-weight Infants
|
N/A | |
Completed |
NCT01479218 -
Safety and Effectiveness Study With a New PDA Occluder for Closure of Patent Ductus Arteriosus
|
N/A | |
Completed |
NCT00795990 -
Timing for the Medical Treatment of Patent Ductus Arteriosus in Preterm Infants
|
N/A | |
Terminated |
NCT00802685 -
Timing of PDA Closure and Respiratory Outcome in Premature Infants
|
N/A | |
Withdrawn |
NCT00554307 -
Brain, Gut and Kidney Blood Flow During Medical Closure of PDA
|
N/A | |
Recruiting |
NCT04397913 -
Population Pharmacokinetics and Dosage Individualization of Paracetamol and Ibuprofen in Children With PDA
|
||
Completed |
NCT02750228 -
PDA Post NICU Discharge
|
||
Recruiting |
NCT02220270 -
Hyperion™ International Registry Trial
|
N/A | |
Completed |
NCT01593163 -
Echocardiographically Guided Versus Standard Ibuprofen Treatment for Patent Ductus Arteriosus
|
Phase 3 | |
Recruiting |
NCT06298344 -
The Role of Thiamine After Transcatheter Closure in Children With Left-to-Right Shunt Congenital Heart Disease
|
Early Phase 1 | |
Completed |
NCT03277768 -
Non-Invasive Detection of Tissue Oxygen Deprivation in Premature Infants With Patent Ductus Arteriosus.
|
||
Completed |
NCT03022253 -
Platelet Transfusion for Treatment of Patent Ductus Arteriosus in Thrombocytopenic Preterm Neonates
|
Phase 3 |